Epidemiology of gastroenteropancreatic neuroendocrine tumours

Best Practice and Research: Clinical Gastroenterology

Volumn 26, Issue 6, 2012, Pages 691-703

  Fraenkel, M ^a   Kim, M K ^b   Faggiano, A ^c,d   Valk, G D ^e  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Carcinoid; Epidemiology; Gastroenteropancreatic neuroendocrine tumours; Incidence; Survival

Indexed keywords

6 FLUORODOPA F 18; PENTETREOTIDE IN 111; PROTON PUMP INHIBITOR;

APPENDIX TUMOR; ARTICLE; ATROPHIC GASTRITIS; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SURVIVAL; COLON TUMOR; COLORECTAL TUMOR; DENMARK; DUODENUM TUMOR; ENDOCRINE TUMOR; GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR; GLUCAGONOMA; HUMAN; ILEUM TUMOR; IRELAND; JEJUNUM TUMOR; MULTIPLE ENDOCRINE NEOPLASIA; NETHERLANDS; NORWAY; PANCREATIC NEUROENDOCRINE TUMOR; POSITRON EMISSION TOMOGRAPHY; RACE DIFFERENCE; RECTUM TUMOR; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOMATOSTATINOMA; STOMACH TUMOR; SURVIVAL RATE; SWEDEN; SWITZERLAND; UNITED KINGDOM; VON HIPPEL LINDAU DISEASE; ZOLLINGER ELLISON SYNDROME;

EID: 84876158014     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2013.01.006     Document Type: Review

References (65)

1. I.M. Modlin, K. Oberg, D.C. Chung, R.T. Jensen, W.W. de Herder, and R.V. Thakker Gastroenteropancreatic neuroendocrine tumours Lancet Oncol 9 1 2008 61 72
2. G. Klöppel, A. Couvelard, A. Perren, P. Komminoth, A.M. McNicol, and O. Nilsson ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification Neuroendocrinology 90 2 2009 162 166
3. I.M. Modlin, M.D. Shapiro, and M. Kidd Siegfried Oberndorfer: origins and perspectives of carcinoid tumors Hum Pathol 35 12 2004 1440 1451
4. G. Kloppel, A. Perren, and P.U. Heitz The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification Ann N Y Acad Sci 1014 2004 13 27
5. T. Ito, H. Sasano, M. Tanaka, R.Y. Osamura, I. Sasaki, and W. Kimura Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan J Gastroenterol 45 2 2010 234 243
6. E.A. Perez, L.G. Koniaris, S.E. Snell, J.C. Gutierrez, W.E. Sumner 3rd, and D.J. Lee 7201 Carcinoids: increasing incidence overall and disproportionate mortality in the elderly World J Surg 31 5 2007 1022 1030
7. D.S. Klimstra, I.R. Modlin, N.V. Adsay, R. Chetty, V. Deshpande, and M. Gönen Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set Am J Surg Pathol 34 3 2010 300 313
8. D.S. Klimstra, I.R. Modlin, D. Coppola, R.V. Lloyd, and S. Suster The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems Pancreas 39 6 2010 707 712
9. B. Lawrence, B.I. Gustafsson, A. Chan, B. Svejda, M. Kidd, and I.M. Modlin The epidemiology of gastroenteropancreatic neuroendocrine tumors Endocrinol Metab Clin North Am 40 1 2011 1 18 [vii]
10. L. Ellis, M.J. Shale, and M.P. Coleman Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971 Am J Gastroenterol 105 12 2010 2563 2569
11. O. Hauso, B.I. Gustafsson, M. Kidd, H.L. Waldum, I. Drozdov, and A.K. Chan Neuroendocrine tumor epidemiology: contrasting Norway and North America Cancer 113 10 2008 2655 2664
12. M.Y. Cho, J.M. Kim, J.H. Sohn, M.J. Kim, K.M. Kim, and W.H. Kim Current trends of the incidence and pathological diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study Cancer Res Treat 44 3 2012 157 165
13. R. Garcia-Carbonero, J. Capdevila, G. Crespo-Herrero, J.A. Díaz-Pérez, M.P. Martínez Del Prado, and V. Alonso Orduña Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE) Ann Oncol 21 9 2010 1794 1803
14. M.B. Niederle, M. Hackl, K. Kaserer, and B. Niederle Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters Endocr Relat Cancer 17 4 2010 909 918
15. A.F. Li, C.Y. Hsu, A. Li, L.C. Tai, W.Y. Liang, and W.Y. Li A 35-year retrospective study of carcinoid tumors in Taiwan: differences in distribution with a high probability of associated second primary malignancies Cancer 112 2 2008 274 283
16. A. Faggiano, P. Ferolla, F. Grimaldi, D. Campana, M. Manzoni, and M.V. Davì Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian Epidemiological study: the NET Management Study J Endocrinol Invest 35 9 2012 817 823
17. T. Lim, J. Lee, J.J. Kim, J.K. Lee, K.T. Lee, and Y.H. Kim Gastroenteropancreatic neuroendocrine tumors: incidence and treatment outcome in a single institution in Korea Asia Pac J Clin Oncol 7 3 2011 293 299
18. R.N. Younes Neuroendocrine tumors: a registry of 1,000 patients Rev Assoc Med Bras 54 4 2008 305 307
19. U. Ploeckinger, G. Kloeppel, B. Wiedenmann, and R. Lohmann The German NET-registry: an audit on the diagnosis and therapy of neuroendocrine tumors Neuroendocrinology 90 4 2009 349 363
20. K.D. Buchanan, C.F. Johnston, M.M. O'Hare, J.E. Ardill, C. Shaw, and J.S. Collins Neuroendocrine tumors. A European view Am J Med 81 6B 1986 14 22
21. R.G. Watson, C.F. Johnston, M.M. O'Hare, J.R. Anderson, B.G. Wilson, and J.S. Collins The frequency of gastrointestinal endocrine tumours in a well-defined population-Northern Ireland 1970-1985 Q J Med 72 267 1989 647 657
22. C. Lombard-Bohas, E. Mitry, D. O'Toole, C. Louvet, D. Pillon, and G. Cadiot Thirteen-month registration of patients with gastroenteropancreatic endocrine tumours in France Neuroendocrinology 89 2 2009 217 222
23. T. Berge, and F. Linell Carcinoid tumours. Frequency in a defined population during a 12-year period Acta Pathol Microbiol Scand A 84 4 1976 322 330
24. J.D. Godwin 2nd Carcinoid tumors. An analysis of 2,837 cases Cancer 36 2 1975 560 569
25. I.M. Modlin, A. Sandor, L.H. Tang, M. Kidd, and D. Zelterman A 40-year analysis of 265 gastric carcinoids Am J Gastroenterol 92 4 1997 633 638
26. X. Zarate, N. Williams, and M.F. Herrera Pancreatic incidentalomas Best Pract Res Clin Endocrinol Metab 26 1 2012 97 103
27. J.C. Yao, M. Hassan, A. Phan, C. Dagohoy, C. Leary, and J.E. Mares One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States J Clin Oncol 26 18 2008 3063 3072
28. K. Hemminki, and X. Li Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden Cancer 92 8 2001 2204 2210
29. P.F. Quaedvlieg, O. Visser, C.B. Lamers, M.L. Janssen-Heijen, and B.G. Taal Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients Ann Oncol 12 9 2001 1295 1300
30. T. Westergaard, M. Frisch, and M. Melbye Carcinoid tumors in Denmark 1978-1989 and the risk of subsequent cancers. A population-based study Cancer 76 1 1995 106 109
31. J.N. Newton, A.J. Swerdlow, I.M. dos Santos Silva, M.P. Vessey, D.G. Grahame-Smith, and P. Primatesta The epidemiology of carcinoid tumours in England and Scotland Br J Cancer 70 5 1994 939 942
32. F. Levi, V.C. Te, L. Randimbison, G. Rindi, and C. La Vecchia Epidemiology of carcinoid neoplasms in Vaud, Switzerland, 1974-97 Br J Cancer 83 7 2000 952 955
33. A. Caldarella, E. Crocetti, and E. Paci Distribution, incidence, and prognosis in neuroendocrine tumors: a population based study from a cancer registry Pathol Oncol Res 17 3 2011 759 763
34. E. Crocetti, E. Buiatti, and A. Amorosi Epidemiology of carcinoid tumours in central Italy Eur J Epidemiol 13 3 1997 357 359
35. C. Lepage, A.M. Bouvier, J.M. Phelip, C. Hatem, C. Vernet, and J. Faivre Incidence and management of malignant digestive endocrine tumours in a well defined French population Gut 53 4 2004 549 553
36. N. Hodgson, L.G. Koniaris, A.S. Livingstone, and D. Franceschi Gastric carcinoids: a temporal increase with proton pump introduction Surg Endosc 19 12 2005 1610 1612
37. J.A. DiSario, R.W. Burt, H. Vargas, and W.P. McWhorter Small bowel cancer: epidemiological and clinical characteristics from a population-based registry Am J Gastroenterol 89 5 1994 699 701
38. F.J. Service, M.M. McMahon, P.C. O'Brien, and D.J. Ballard Functioning insulinoma-incidence, recurrence, and long-term survival of patients: a 60-year study Mayo Clin Proc 66 7 1991 711 719
39. F. Levi, L. Randimbison, S. Franceschi, and C. La Vecchia Descriptive epidemiology of malignant carcinoids in the Swiss Canton of Vaud Int J Cancer 53 6 1993 1036 1037
40. G.H. Ballantyne, P.E. Savoca, J.T. Flannery, M.H. Ahlman, and I.M. Modlin Incidence and mortality of carcinoids of the colon. Data from the Connecticut Tumor Registry Cancer 69 10 1992 2400 2405
41. M. Alsina, R. Marcos-Gragera, J. Capdevila, M. Buxó, R.M. Ortiz, and P. Barretina Neuroendocrine tumors: a population-based study of incidence and survival in Girona Province, 1994-2004 Cancer Epidemiol 35 6 2011 e49 54
42. H. Scherübl, G. Cadiot, R.T. Jensen, T. Rösch, U. Stölzel, and G. Klöppel Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems? Endoscopy 42 8 2010 664 671
43. P. Ruszniewski, G. Delle Fave, G. Cadiot, P. Komminoth, D. Chung, and B. Kos-Kudla Well-differentiated gastric tumors/carcinomas Neuroendocrinology 84 3 2006 158 164
44. M.A. Maggard, J.B. O'Connell, and C.Y. Ko Updated population-based review of carcinoid tumors Ann Surg 240 1 2004 117 122
45. I.M. Modlin, K.D. Lye, and M. Kidd A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem? Am J Gastroenterol 99 1 2004 23 32
46. U. Plöckinger, G. Rindi, R. Arnold, B. Eriksson, E.P. Krenning, and W.W. de Herder Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS) Neuroendocrinology 80 6 2004 394 424
47. I.M. Modlin, K.D. Lye, and M. Kidd A 5-decade analysis of 13,715 carcinoid tumors Cancer 97 4 2003 934 959
48. R.T. Jensen Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas Basic Clin Pharmacol Toxicol 98 1 2006 4 19
49. N.S. Abraham Proton pump inhibitors: potential adverse effects Curr Opin Gastroenterol 28 6 2012 615 620
50. V.L. Tsikitis, B.C. Wertheim, and M.A. Guerrero Trends of incidence and survival of gastrointestinal neuroendocrine tumors in the United States: a seer analysis J Cancer 3 2012 292 302
51. I.M. Modlin, and A. Sandor An analysis of 8305 cases of carcinoid tumors Cancer 79 4 1997 813 829
52. C. Lepage, L. Ciccolallo, R. De Angelis, A.M. Bouvier, J. Faivre, and G. Gatta European disparities in malignant digestive endocrine tumours survival Int J Cancer 126 12 2010 2928 2934
53. I.M. Modlin, M.C. Champaneria, A.K. Chan, and M. Kidd A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress Am J Gastroenterol 102 7 2007 1464 1473
54. C. Lepage, A.M. Bouvier, S. Manfredi, V. Dancourt, and J. Faivre Incidence and management of primary malignant small bowel cancers: a well-defined French population study Am J Gastroenterol 101 12 2006 2826 2832
55. B.I. Gustafsson, L. Siddique, A. Chan, M. Dong, I. Drozdov, and M. Kidd Uncommon cancers of the small intestine, appendix and colon: an analysis of SEER 1973-2004, and current diagnosis and therapy Int J Oncol 33 6 2008 1121 1131
56. T. Haselkorn, A.S. Whittemore, and D.E. Lilienfeld Incidence of small bowel cancer in the United States and worldwide: geographic, temporal, and racial differences Cancer Causes Control 16 7 2005 781 787
57. T.R. Halfdanarson, J. Rubin, M.B. Farnell, C.S. Grant, and G.M. Petersen Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors Endocr Relat Cancer 15 2 2008 409 427
58. D.J. Kwekkeboom, E.P. Krenning, K. Scheidhauer, V. Lewington, R. Lebtahi, and A. Grossman ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: somatostatin receptor imaging with (111)In-pentetreotide Neuroendocrinology 90 2 2009 184 189
59. A. Sundin, M.P. Vullierme, G. Kaltsas, and U. Plöckinger ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations Neuroendocrinology 90 2 2009 167 183
60. J.C. Yao, M.P. Eisner, C. Leary, C. Dagohoy, A. Phan, and A. Rashid Population-based study of islet cell carcinoma Ann Surg Oncol 14 12 2007 3492 3500
61. T.R. Halfdanarson, K.G. Rabe, J. Rubin, and G.M. Petersen Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival Ann Oncol 19 10 2008 1727 1733
62. C.R. Pieterman, M.R. Vriens, K.M. Dreijerink, R.B. van der Luijt, and G.D. Valk Care for patients with multiple endocrine neoplasia type 1: the current evidence base Fam Cancer 10 1 2011 157 171
63. E.R. Maher, H.P. Neumann, and S. Richard von Hippel-Lindau disease: a clinical and scientific review Eur J Hum Genet 19 6 2011 617 623
64. R.V. Thakker, P.J. Newey, G.V. Walls, J. Bilezikian, H. Dralle, and P.R. Ebeling Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1) J Clin Endocrinol Metab 97 9 2012 2990 3011
65. E. Crocetti, and E. Paci Malignant carcinoids in the USA, SEER 1992-1999. An epidemiological study with 6830 cases Eur J Cancer Prev 12 3 2003 191 194